Your English writing platform
Discover LudwigSuggestions(1)
Exact(9)
This behavior is expected, considering the phase boundary between the two-phase and Ni3Ge regions in a recently published phase diagram.
In a recently published phase II clinical trial, the use of sorafenib in combination with TACE for BCLC stage B and C HCC patients was recommended.
Pemetrexed, a novel multitargeted antifolate, was compared to single-agent docetaxel in a recently published phase III trial (Hanna et al, 2004).
The efficacy of the combining use of sorafenib and TACE in patients with advanced HCC including those with BCLC stage C disease was suggested in a recently published phase II clinical trial [ 17].
In a recently published phase II study, El-Rayes and colleagues treated 47 patients with advanced or metastasised pancreatic cancer with a combination of gemcitabine, cisplatin and 5-FU.
Cediranib, an oral TKI of vascular endothelial growth factor receptor (VEGFR -1, VEGFR -1 VEGFR-2, and c-kit, showed interesting single-agent activity in a recently published Phase II trial in patients with relapsed ovarian candinoma.
Similar(51)
This finding is in keeping with a recently published phase II trial with the pan-deacetylase inhibitor panobinostat, which reported that 74.1% patients achieved a reduction in baseline mSWAT score, while only 17.3% could be classed as achieving disease response (Duvic et al, 2013).
6 A recently published phase III trial in 641 patients receiving their first cycle of a new multiday moderately or highly emetogenic chemotherapeutic regimen demonstrated the noninferiority of GTDS compared with oral granisetron in the primary end point of complete CINV control (60% vs 65%, respectively; difference −5%[95%% confidence interval −13%, +3%]).
A recently published phase II study in 26 relapsed/refractory MCL patients examined lenalidomide dosed at 25 mg/days, days 1 21/28 for six or less cycles, with lower maintenance lenalidomide 15 mg/day, days 1 21/28 in responders until PD/intolerability [ 14].
Although an updated treatment scheme based on a recently published phase I trial may show better outcome in future trials (Plummer et al. 2009).
Of note, the consistently very low current probabilities (poor strength of evidence) of observing mortality reduction with Low-Dose Steroids in both of our analyses (questions 1 and 2) was just confirmed by a recently published phase III trial [66].
Write better and faster with AI suggestions while staying true to your unique style.
Since I tried Ludwig back in 2017, I have been constantly using it in both editing and translation. Ever since, I suggest it to my translators at ProSciEditing.

Justyna Jupowicz-Kozak
CEO of Professional Science Editing for Scientists @ prosciediting.com